Because CK and EpCAM are both heterogeneously expressed on tumor cells (Figures 3 and 4(d)) [15,19,48], the enrichment with the combined antibodies may increase the sensitivity and reproducibility by the compensation effect of biomarkers from each other. The gene discussed is EPCAM; the disease is neoplasm.